Home/ Supplements/ Omega 3/ Adult Gummy Omega-3 Complex with EPA/DHA

Adult Gummy Omega-3 Complex with EPA/DHA

product on market Gummy or Jelly Spring Valley Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 57% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product contains fish oil providing EPA and DHA, which are supported by strong evidence for maintaining cardiovascular and cognitive health. These omega-3 fatty acids help regulate lipid levels and support brain function. The formulation is considered safe for general consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Adult Gummy Omega-3 Complex with EPA/DHA
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Gummie(s)
Serving Size
Fat/Fatty Acid
Product Type
57%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Carbohydrates
4 Gram(s)
Sugar
3 Gram(s)
227 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Formulation Notes

No gluten, wheat, milk, egg, artificial colors or flavors No added preservatives

Additional Information

Vitamin #1 brand

No fishy aftertaste Natural fruit flavors Heart health

Metadata

Product Details

DSLD Entry Date2017-04-25
Product TypeFat/Fatty Acid
FormGummy or Jelly
DSLD ID73430
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.